Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Centre Hospitalier Universitaire Grenoble Alpes
Sponsor

Centre Hospitalier Universitaire Grenoble Alpes

France Boulevard De La Chantourne, Cs 10217, La Tronche, 38043 Grenoble, France

About the sponsor

Clinical research spans stroke, subarachnoid hemorrhage, head trauma, herpes simplex virus encephalitis, and neurocognitive disorders with agitation in older adults. Additional interest includes acute anterior ischemic optic neuropathy and hyponatremia in the setting of cerebral hemorrhage.

  • Stroke and subarachnoid hemorrhage
  • Traumatic brain injury and head trauma
  • Encephalitis and acute neurocognitive disorders
  • Optic neuropathy

Research activity also covers symptom control and supportive care in acute neurological illness, including management of pain, agitation, and metabolic complications.

About Specializations

Centre Hospitalier Universitaire Grenoble Alpes runs clinical trials in conditions such as Subarachnoid haemorrhage, Breast cancer, Atrial fibrillation, Thrombosis prophylaxis, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

12 clinical trials

Subarachnoid haemorrhage

Recruiting

Study on the Effectiveness of Sphenopalatine Block for Headache Relief in Patients with Subarachnoid Hemorrhage Using Lidocaine Hydrochloride

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Paracetamol
  • Sponsor:Centre Hospitalier Universitaire Grenoble Alpes

Breast cancer

Recruiting

Study on Edotreotide for Detecting Somatostatin Receptors in Patients with Metastatic Breast Cancer

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Edotreotide
  • Sponsor:Centre Hospitalier Universitaire Grenoble Alpes

Atrial fibrillation

Not yet recruiting

A study on the effect of hydrogen inhalation therapy to prevent the early return of atrial fibrillation in patients after heart ablation treatment.

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Hydrogen
  • Sponsor:Centre Hospitalier Universitaire Grenoble Alpes

Thrombosis prophylaxis

Not yet recruiting

Comparing intermediate and standard doses of enoxaparin to prevent blood clots in patients with severe trauma

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Enoxaparin Sodium
  • Sponsor:Centre Hospitalier Universitaire Grenoble Alpes

Depression

Not yet recruiting

Study of prucalopride and escitalopram combination to improve treatment response in patients with major depressive disorder

Registered drug
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Escitalopram
  • Sponsor:Centre Hospitalier Universitaire Grenoble Alpes

Neonatal respiratory distress syndrome

Not recruiting

Study on the Effects of Propofol Sedation in Preterm Babies with Respiratory Distress Syndrome During LISA Procedure

Registered drug
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Propofol
  • Sponsor:Centre Hospitalier Universitaire Grenoble Alpes

Subarachnoid haemorrhage+1

Not recruiting

Study on Urea for Treating Low Sodium Levels in Patients with Brain Hemorrhage

Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Urea
  • Sponsor:Centre Hospitalier Universitaire Grenoble Alpes

Human herpesvirus 6 encephalitis

Not recruiting

Study on Dexamethasone for Patients with Herpes Simplex Virus Encephalitis

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Dexamethasone
  • Sponsor:Centre Hospitalier Universitaire Grenoble Alpes

Optic ischaemic neuropathy

Not recruiting

Study on the Effects of Bosentan for Patients with Early Stage Non-Arteritic Anterior Ischemic Optic Neuropathy

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Bosentan
  • Sponsor:Centre Hospitalier Universitaire Grenoble Alpes

Arteriosclerosis

Not recruiting

Study on the Effect of Evolocumab on Heart Disease in Patients Needing Coronary Angiography

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Evolocumab
  • Sponsor:Centre Hospitalier Universitaire Grenoble Alpes

Cognitive disorder

Not recruiting

Study on the Effectiveness and Safety of Oral Midazolam for Elderly Patients with Severe Neurocognitive Disorders and Care Resistance

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Midazolam
  • Sponsor:Centre Hospitalier Universitaire Grenoble Alpes

Hepatocellular carcinoma

Not recruiting

Study of Ezurpimtrostat with Atezolizumab and Bevacizumab for Patients with Unresectable Liver Cancer

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Centre Hospitalier Universitaire Grenoble Alpes

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.